2726
S. Norsikian et al. / Carbohydrate Research 342 (2007) 2716–2728
CO2CH3), 1.99 (s, 3H, CO2CH3), 2.05 (s, 3H, CO2CH3),
2.10 (s, 3H, CO2CH3), 2.36 (s, 3H, C-1), 3.69–3.75 (m,
2H, H-8 and OH), 4.05 (dd, 1H, J4,5 1, J4,3 6 Hz, H-
4), 4.21 (dd, 1H, J9a,8 2.5, J9a,9b 12 Hz, H-9a), 4.24–
4.30 (m, 2H, H-9b, H-3), 5.03 (dd, 1H, J6,5 3, J6,7
10 Hz, H-6), 5.23 (t, 1H, J7,8 = J7,6 10 Hz, H-7), 5.54
(dd, 1H, J5,4 1, J5,6 3 Hz, H-5); 13C NMR (100 MHz,
CDCl3): d (ppm) 20.1, 20.5, 20.6, 20.7 (4 · CO2CH3),
27.4 (C-1), 62.4 (C-9), 65.9 (C-7), 66.0 (C-5), 71.6 (C-
6), 74.4 (C-3), 76.8 (C-8), 77.5 (C-4), 169.4, 169.6,
169.9, 170.5 (CO2CH3), 207.8 (C-2); ESIMS: m/z =
427 [(M+Na)+, 100%]; ESIHRMS: m/z 427.1211.
C17H24O11Na1 requires 427.1211; Anal. Calcd for
C17H24O11: C, 50.49; H, 5.98; O, 43.52. Found: C,
128.2, 128.3, 128.4, 128.8 (Ph), 138.7 (Cq Ph), 155.0
(C-2), 169.3, 170.0, 170.2 (CO); ESIMS: m/z = 523
[(M+H)+, 30%]. Compound 7e: mmax (thin film): 2944,
1
1740, 1598, 1434, 1369, 1220, 1041, 910, 742 cmꢀ1; H
NMR (400 MHz, CDCl3): d (ppm) 1.99 (s, 3H,
CO2CH3), 2.02 (s, 3H, CO2CH3), 2.06 (s, 3H, CO2CH3),
2.14 (s, 3H, CO2CH3), 2.64–2.82 (m, 4H, N–CH2–),
3.54–3.60 (m, 3H, CH2Ph and H-1), 3.68–3.73 (m, 2H,
CH2Ph and H-2), 3.77 (ddd, 1H, J6,7a 2, J6,7b 6, J6,5
9 Hz, H-6), 4.19 (dd, 1H, J7a,6 2, J7a,7b 12 Hz, H-7a),
4.26 (dd, 1H, J7b,6 6, J7a,7b 12 Hz, H-7b), 4.34 (d, 1H,
J 13 Hz, CH2Ph), 5.13 (dd, 1H, J4,3 3, J4,5 9 Hz, H-4),
5.29 (t, 1H, J5,4 = J5,6 9 Hz, H-5), 5.91 (d, 1H, J3,4
3 Hz, H-3), 7.20–7.50 (m, 10H, Ph); 13C NMR
(90 MHz, CDCl3): d (ppm) 20.6, 20.7, 20.9 (CH3CO2),
49.5 (CH2–N), 49.7 (CH2–N), 60.4 (CH2-Ph), 60.7
(CH2-Ph), 63.3 (C-7), 66.6 (C-5), 69.2 (C-3), 72.7 (C-
4), 76.5 (C-6), 81.4 (C-2), 83.6 (C-1), 126.9, 127.2,
128.2, 128.3, 128.7, 130.0 (Ph), 138.7, 138.9 (Cq Ph),
169.8, 170.1, 170.2, 170.8 (CO); ESIMS: m/z = 605
[(M+Na)+, 100%]; ESIHRMS: m/z 605.24926.
C31H38O9N2Na1 requires 605.2470.
25
50.33; H, 5.94; O, 43.31. Compound 5e: ½aꢁD ꢀ43.8 (c
1, CHCl3); mmax (thin film): 2954, 1737, 1371, 1219,
1044, 962, 906, 734 cmꢀ1; 1H NMR (400 MHz, CDCl3):
d (ppm) 1.94 (s, 3H, CO2CH3), 2.00 (s, 3H, CO2CH3),
2.04 (s, 3H, CO2CH3), 2.14 (s, 3H, CO2CH3), 2.36–
2.43 (dd, 1H, J3a,4 4, J3a,3b 16 Hz, H-3a), 2.69–2.77
(dd, 1H, J3b,4 9, J3b,3a 16 Hz, H-3b), 3.65 (ddd, J8,9a 2,
J8,9b 6, J8,7 10 Hz, 1H, H-8), 4.03 (dd, 1H, J9a,8 2,
J9a,9b 12 Hz, H-9a), 4.17–4.24 (m, 4H, H-4, H-9b, H-
1a and H-1b), 5.07 (dd, 1H, J6,5 3, J6,7 10 Hz, H-6),
5.17 (t, 1H, J7,6 = J7,8 10 Hz, H-7), 5.31 (d, 1H, J5,6
3 Hz, H-5); 13C NMR (100 MHz, CDCl3): d (ppm)
20.4, 20.6 (4 · CO2CH3), 39.5 (C-3), 62.4 (C-9), 65.8
(C-7), 68.8 (C-1), 69.8 (C-5), 71.9 (C-6), 72.6 (C-4),
76.2 (C-8), 169.6, 169.9, 170.4, 170.6 (CO2CH3), 206.4
(C-2); ESIMS: m/z = 427 [(M+Na)+, 100%]; ESI-
HRMS: m/z 427.1211. C17H24O11Na1 requires 427.1211.
3.14. 5-N-Acetylacetamido-6,7,9-tri-O-acetyl-4,8-
anhydro-1,5-dideoxy-D-erythro-L-talo-non-2-ulose (4g)
and 5-acetamido-6,7,9-tri-O-acetyl-4,8-anhydro-1,5-di-
deoxy-D-erythro-L-talo-non-2-ulose (13)
The enolisation reaction was performed on 1g (0.429 g,
1 mmol) according to general procedure A in 6:5
MeCN–cyclohexane (2.75 mL) using pyridine (0.4 mL),
TMSCl (0.64 mL) and NaI (0.74 g) for a night at
70 ꢁC. To this crude residue was added DMDO
(30 mL, 0.1 M in acetone, 3 equiv). The soln was stirred
for 2 h at rt and concentrated. Flash chromatography
(1:1 petroleum ether–EtOAc + 0.1% NEt3) gave 4g
3.13. Bis(phenylmethyl)imidazolidine of the 3,4,5,7-tetra-
O-acetyl-2,6-anhydro-D-glycero-D-galacto-heptose (7e)
Aminal 7e was then synthesised according to general
procedure C. The reaction was performed with crude
4e (75.6 mg, 0.159 mmol) using NaIO4 (120 mg) for
3 h. After work-up, treatment with N,N-dibenzylethyl-
enediamine, then flash chromatography (17:3 toluene–
EtOAc), 12 (22.7 mg, 27%) closely followed by 7e
(47.6 mg, 51% from 1e) were obtained. Compound 12:
mmax (ATR-FT IR, diamond prism): 2923, 1741, 1367,
20
(0.311 g, 70%): ½aꢁD +2.4 (c 1, CHCl3); mmax (thin film):
3465, 1749, 1717, 1368, 1226, 1047 cmꢀ1 1H NMR
;
(250 MHz, CDCl3):
d (ppm) 1.92–2.00 (m, 9H,
3 · CH3), 2.15 (s, 3H, CH3), 2.29 (s, 3H, CH3), 2.41 (s,
3H, CH3), 3.69 (ddd, 1H, J8,9a 2.5, J8,9b 6, J8,7 9.5 Hz,
H-8), 3.74–3.82 (br s, 1H, OH), 3.91 (dd, 1H, J9a,8 2.5,
J9a,9b 13 Hz, H-9a), 3.97–4.06 (m, 2H, H-5 and H-3),
4.08 (dd, 1H, J9b,8 6, J9a,9b 13 Hz, H-9b), 4.92 (dd, 1H,
J7,8 9, J7,6 10 Hz, H-7), 5.02 (dd, 1H, J4,3 2.5, J4,5
10 Hz, H-4), 5.76 (dd, 1H, J6,5 9, J6,7 10 Hz, H-6); 13C
NMR (90 MHz, CDCl3): d (ppm) 20.3, 24.6, 24.8, 27.5
(CH3), 58.0 (C-3), 62.4 (C-9), 69.6 (C-7), 70.9 (C-6),
75.1 (C-5), 76.2 (C-4 and C-8), 169.6, 169.7, 170.4,
174.6, 175.2, (5 · CO2CH3), 205.0 (C-2); ESIMS:
m/z = 468 [(M+Na)+,100%]; Anal. Calcd. for
C19H27O11N: C, 51.23; H, 6.11; O, 39.51; N, 3.14.
Found: C, 50.97; H, 6.12; O, 39.74; N, 2.93. If the oxi-
dation of 1g is carried out in the presence of K2CO3, a
1
1218, 1048, 909, 741, 699 cmꢀ1; H NMR (400 MHz,
CDCl3): d (ppm) 2.03–2.08 (m, 9H, CO2CH3), 2.56–
2.62 (m, 2H, N–CH2–), 3.04–3.11 (m, 2H, N–CH2–),
3.51 (d, 1H, J 13 Hz, CH2-Ph), 3.53 (d, 1H, J 13 Hz,
CH2-Ph), 3.60 (s, 1H, H-1), 3.93 (d, 1H, J 13 Hz,
CH2-Ph), 3.96 (d, 1H, J 13 Hz, CH2-Ph), 4.21–4.41 (m,
3H, H-6, H-7a and H-7b), 5.10 (d, 1H, J3,4 4 Hz, H-3),
5.19 (dd, 1H, J5,4 4, J5,6 6 Hz, H-5), 5.90 (t, 1H,
J4,5 = J4,3 4 Hz, H-4), 7.20–7.50 (m, 10H, Ph); 13C
NMR (90 MHz, CDCl3): d (ppm) 20.4, 20.5, 20.8
(CH3CO2), 50.4 (CH2–N), 50.5 (CH2–N), 57.1 (CH2-
Ph), 59.8 (CH2-Ph), 61.1 (C-7), 67.0, 67.1 (C-4, C-5),
73.8 (C-6), 84.8 (C-1), 98.1 (C-3), 126.7, 127.1, 128.1,
20
substantial amount of 13 is formed. ½aꢁD ꢀ32.8 (c 1,
CHCl3); mmax (ATR-FT IR, diamond prism): 2988,